IRIS
AGAMENNONE, Mariangela
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.067
EU - Europa 2.378
AS - Asia 2.335
Continente sconosciuto - Info sul continente non disponibili 367
SA - Sud America 342
AF - Africa 35
OC - Oceania 5
Totale 9.529
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.924
SG - Singapore 923
CN - Cina 655
IT - Italia 521
IE - Irlanda 327
BR - Brasile 275
UA - Ucraina 267
SE - Svezia 252
RU - Federazione Russa 243
GB - Regno Unito 232
VN - Vietnam 219
TR - Turchia 212
DE - Germania 185
IN - India 173
FR - Francia 120
CA - Canada 75
FI - Finlandia 71
GR - Grecia 40
BD - Bangladesh 37
HK - Hong Kong 33
AR - Argentina 21
MX - Messico 21
PL - Polonia 20
JP - Giappone 15
LT - Lituania 15
NL - Olanda 15
EC - Ecuador 13
ES - Italia 13
PT - Portogallo 13
IQ - Iraq 12
AT - Austria 11
ZA - Sudafrica 10
ID - Indonesia 9
VE - Venezuela 9
BE - Belgio 8
CO - Colombia 8
EG - Egitto 7
KR - Corea 7
NI - Nicaragua 7
CH - Svizzera 6
CZ - Repubblica Ceca 6
GT - Guatemala 6
HN - Honduras 6
CR - Costa Rica 5
EU - Europa 5
PK - Pakistan 5
PR - Porto Rico 5
RO - Romania 5
UZ - Uzbekistan 5
CI - Costa d'Avorio 4
CL - Cile 4
JM - Giamaica 4
PE - Perù 4
PY - Paraguay 4
TT - Trinidad e Tobago 4
AU - Australia 3
DZ - Algeria 3
EE - Estonia 3
IR - Iran 3
KZ - Kazakistan 3
MA - Marocco 3
MY - Malesia 3
PH - Filippine 3
SA - Arabia Saudita 3
SV - El Salvador 3
AE - Emirati Arabi Uniti 2
BB - Barbados 2
BG - Bulgaria 2
BH - Bahrain 2
CY - Cipro 2
GP - Guadalupe 2
HU - Ungheria 2
IL - Israele 2
JO - Giordania 2
LY - Libia 2
UY - Uruguay 2
AL - Albania 1
BO - Bolivia 1
CW - ???statistics.table.value.countryCode.CW??? 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
GE - Georgia 1
GY - Guiana 1
KE - Kenya 1
KN - Saint Kitts e Nevis 1
KW - Kuwait 1
LB - Libano 1
MG - Madagascar 1
NP - Nepal 1
PA - Panama 1
PS - Palestinian Territory 1
SC - Seychelles 1
TG - Togo 1
TN - Tunisia 1
TO - Tonga 1
TV - Tuvalu 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 9.169
Salva come PNG Salva come JPEG
Città #
Singapore 651
San Jose 548
Chandler 334
Jacksonville 334
Dublin 324
Ashburn 276
Dallas 167
Council Bluffs 161
Beijing 144
Southend 144
Princeton 141
Nanjing 116
Izmir 107
Chieti 104
Los Angeles 90
Santa Clara 88
Cambridge 72
Ho Chi Minh City 68
Ann Arbor 65
Dearborn 65
Munich 62
New York 62
Nanchang 55
The Dalles 54
Wilmington 48
Rome 41
Tongling 41
Altamura 39
Buffalo 38
Woodbridge 38
Columbus 34
Hong Kong 33
Hanoi 30
Washington 29
Redondo Beach 26
Dong Ket 25
São Paulo 25
Phoenix 23
Shenyang 23
Ottawa 22
Orem 21
Hebei 19
Kunming 19
Milan 19
Moscow 19
San Mateo 19
Tianjin 19
Atlanta 18
Denver 18
Montreal 17
St Louis 17
Stockholm 17
Da Nang 16
Jiaxing 16
London 16
Nuremberg 16
Chicago 15
Grevenbroich 15
Toronto 15
Boardman 14
Warsaw 14
Brooklyn 13
Changsha 13
Haiphong 13
North Bergen 13
Pune 13
Hefei 12
Manchester 12
Norwalk 12
Tokyo 12
Ferrara 11
Kimball 11
Poplar 11
Porto 11
San Francisco 11
Vilnius 11
Andover 10
Augusta 10
Houston 10
Mexico City 10
Mount Pleasant 10
Rio de Janeiro 10
Turku 10
Jinan 9
Naples 9
Napoli 9
Pescara 9
Shanghai 9
Bari 8
Curitiba 8
Seattle 8
Siena 8
Teramo 8
Ankara 7
Belo Horizonte 7
Brasília 7
Brussels 7
Hangzhou 7
Johannesburg 7
Leawood 7
Totale 5.489
Salva come PNG Salva come JPEG
Nome #
Peptidi della Lattoferrina per uso come inibitori ad ampio spettro dell'infezione da virus dell'influenza 288
AMBER force field implementation of the boronate function to simulate the inhibition of beta-lactamases by alkyl and aryl boronic acids 176
Synthesis and evaluation of new tripeptide phosphonate inhibitors of MMP-8 and MMP-2 175
Dual targeting of cancer-related human matrix metalloproteinases and carbonic anhydrases by chiral N-(biarylsulfonyl)-phosphonic acids 174
Inibitori fosfonati di MMP: Influenza di variazioni strutturali in P3 sulla potenza e sulla selettività d’azione. 162
PPARα agonists based on stilbene and its bioisosteres: Biological evaluation and docking studies 160
alpha-Biphenylsulfonylamino 2-methylpropyl phosphonates: enantioselective synthesis and selective inhibition of MMPs. 159
Lactoferrin derived peptides for use as broad- spectrum inhibitors of influenza virus infection 158
Derivatives of m-aminophenylboronic acid as ß-lactamases inhibitors. 153
Tripeptide Phosphonate Inhibitors of Matrix metalloproteinases. 152
Structural insight into the stereoselective inhibition of MMP-8 by enantiomeric sulphonamide phosphonates 149
Bovine lactoferrin-derived peptides as novel broad-spectrum inhibitors of influenza virus 147
Characterization of PD-L1 binding sites by a combined FMO/GRID-DRY approach 146
Benzothiazole Derivatives Endowed with Antiproliferative Activity in Paraganglioma and Pancreatic Cancer Cells: Structure-Activity Relationship Studies and Target Prediction Analysis 144
Sintesi e valutazione biologica di Acidi Aril-Solfonil-Fosfonici come Inibitori selettivi delle Metalloproteinasi di Matrice (MMP). 142
Sintesi enantioselettiva di inibitori fosfonati di metalloproteinasi di matrice. 141
Bisphosfonate matrix metalloproteinase inhibitors for the treatment of periodontitis: An in vitro study 141
An Integrated Computational Approach to Rationalize the Activity of Non-Zinc-Binding MMP-2 Inhibitors 140
Amber* force field implementation to dock alkyl and aryl boronic acids as ß-lactamases inhibitors. 140
New Matrix Metalloproteinase Inhibitors Based on N-hydroxyurea as zinc-binding group: synthesis, biological evaluation and computational studies. 138
Seeking for Non-Zinc-Binding MMP-2 Inhibitors: Synthesis, Biological Evaluation and Molecular Modelling Studies 137
In vitro comparison of new bisphosphonic acids and zoledronate effects on human gingival fibroblasts viability, inflammation and matrix turnover 136
Synthesis and biological evaluation of new matrix metalloproteinases inhibitors 134
Synthesis and biological evaluation of new Matrix Metalloproteinases Inhibitors. 134
Phosphonate Emerging Zinc Binding Group in Matrix Metalloproteinase Inhibitors 132
Catechol-based matrix metalloproteinase inhibitors with additional antioxidative activity 132
Amino Acid Derivatives as New Zinc Binding Groups for the Design of Selective Matrix Metalloproteinase Inhibitors 131
Azo derivatives of monoterpenes as anti-Helicobacter pylori agents: from synthesis to structure-based target investigation 130
Synthesis, SAR and Biological Evaluation of alfa-Sulfonylphosphonic Acid as Selective Matrix Metalloproteinase Inhibitor 130
Coumarin-Based Dual Inhibitors of Human Carbonic Anhydrases and Monoamine Oxidases Featuring Amino Acyl and (Pseudo)-Dipeptidyl Appendages: In Vitro and Computational Studies 129
VIRTUAL SCREENING APPROACHES FOR THE IDENTIFICATION OF NOVEL NON-ZINC-BINDING MMPs INHIBITORS 129
Biphenyl Sulfonylamino Methyl Bisphosphonic Acids as Inhibitors of Matrix Metalloproteinases and Bone Resorption 129
Bovine lactoferrin prevents influenza a virus infection by interfering with the fusogenic function of viral hemagglutinin 129
N-Hydroxyurea as zinc binding group in matrix metalloproteinase inhibition: Mode of binding in a complex with MMP-8 128
Synthesis and biological evaluation of sulfonyl phosphonic acids as new MMPs inhibitors. 128
In vitro comparison of new bisphosphonic acids and zoledronate effects on human gingival fibroblasts viability, inflammation and matrix turnover 127
Ac‑tLeu‑Asp‑H is the minimal and highly effective human caspase‑3 inhibitor: biological and in silico studies 125
N-idrossiuree come inibitori di metalloproteinasi di matrice. 122
AMBER force field parameterization for alkyl and aryl boronic acids. 120
Bone-Seeking Matrix Metalloproteinase Inhibitors for the Treatment of Skeletal Malignancy 119
(2-Aminobenzothiazole)-Methyl-1,1-bisphosphonic acids: Targeting matrix metalloproteinase 13 inhibition to the bone 119
Identification of new anti-Candida compounds by ligand-based pharmacophore virtual screening 116
Arylamino methylene bisphosphonate derivatives as bone seeking matrix metalloproteinase inhibitors 115
Antiviral Peptides as Anti-Influenza Agents 115
Probing the S1′ Site for the Identification of Non-Zinc-Binding MMP-2 Inhibitors 114
Peptidyl 3-substituted 1-hydroxyureas as isosteric analogues of succinylhydroxamate MMP inhibitors 114
Fragmenting the S100B–p53 Interaction: CombinedVirtual/Biophysical Screening Approaches to IdentifyLigands 113
Mode of binding of R- and S- sulfonamide phosphonate inhibitors in the active site of MMP-8. 111
An Effective Virtual Screening Protocol to Identify Promising p53-MDM2 Inhibitors 111
Effects of Biphenyl Sulfonylamino Methyl Bisphosphonic Acids on Porphyromonas Gingivalis and Cytokine Secretion by Oral Epithelial Cells 109
Lactoferrin-derived Peptides Active towards Influenza: Identification of Three Potent Tetrapeptide Inhibitors 107
synthesis and Activity of Endomorphin-1 and 2 analogues Incorporating Azetidine-(S)-2-carboxylic acid and Azetidine-3-carboxylic acid in place of native proline 105
Fragment-based discovery of S100B inhibitors: when structural information meets in silico prediction. 105
Non-zinc-binding inhibitors of MMP-13: GRID-based approaches to rationalize the binding process 104
Identification of small molecules acting against H1N1 influenza A virus 103
Multiple virtual screening approaches to identify novel, non-hydroxamic class-I HDAC inhibitors. 101
Novel bisphosphonates with antiresorptive effect in bone mineralization and osteoclastogenesis 98
Resveratrol Analogues as Dual Inhibitors of Monoamine Oxidase B and Carbonic Anhydrase VII: A New Multi-Target Combination for Neurodegenerative Diseases? 96
Benzenesulfonamide derivatives as Vibrio cholerae carbonic anhydrases inhibitors: a computational-aided insight in the structural rigidity-activity relationships 95
Mimic catechins to develop selective MMP-2 inhibitors 95
Fragment-based discovery of S100B inhibitors combining computational and biophysical approaches. 90
Development of CDK4/6 Inhibitors: A Five Years Update 90
Protein-protein interactions at a glance: Protocols for the visualization of biomolecular interactions 89
Structure-based pharmacophore mapping of flexible macromolecules: targeting the S100B – p53 interaction. 88
Matrix metalloproteinases inhibitors, synthesis and biological evaluation. 88
Rational Design of Novel Peptidomimetics against Influenza A Virus: Biological and Computational Studies 86
Hampering the early aggregation of PrP-E200K protein by charge-based inhibitors: a computational study 86
Investigation of the N-BP Binding at FPPS by Combined Computational Approaches 85
Fragment-Based Discovery of 5-Arylisatin-Based Inhibitors of Matrix Metalloproteinases 2 and 13 83
A Comprehensive Computational Insight into the PD-L1 Binding to PD-1 and Small Molecules 81
Inhibition of Human Coronavirus 229E by Lactoferrin-Derived Peptidomimetics 79
Discovery of a novel tetrapeptide against influenza a virus: Rational design, synthesis, bioactivity evaluation and computational studies 79
Virtual screening identification and chemical optimization of substituted 2-arylbenzimidazoles as new non-zinc-binding MMP-2 inhibitors 78
Identification of Anti-Influenza A Compounds Inhibiting the Viral Non-Structural Protein 1 (NS1) Using a Type I Interferon-Driven Screening Strategy 74
Erlotinib-containing benzenesulfonamides as anti-Helicobacter pylori agents through carbonic anhydrase inhibition 74
Broad-Spectrum Activity of Small Molecules Acting against Influenza a Virus: Biological and Computational Studies 67
Het(aryl)isatin to het(aryl)aminoindoline scaffold hopping: A route to selective inhibitors of matrix metalloproteinases 66
Inhibition of Pseudomonas aeruginosa Carbonic Anhydrases, Exploring Ciprofloxacin Functionalization Toward New Antibacterial Agents: An In-Depth Multidisciplinary Study 65
Discovery of 7-aminophenanthridin-6-one as a new scaffold for matrix metalloproteinase inhibitors with multitarget neuroprotective activity 62
Design and Evaluation of Synthesized Pyrrole Derivatives as Dual COX-1 and COX-2 Inhibitors Using FB-QSAR Approach 45
Targeting microbial β-CAs: bridging in silico screening with in vitro validation 36
Discovery and Evaluation of Novel Sulfonamide Derivatives Targeting Aromatase in ER+ Breast Cancer 20
Synthesis and Assessment of the Enantioselectivity in Antitumor Activity of a Library of Novel Chiral Flavone Derivatives 6
Totale 9.529
Salva come PNG Salva come JPEG
Categoria #
all - tutte 38.560
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 38.560
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022328 0 0 0 85 27 4 4 21 26 11 46 104
2022/20231.003 98 122 72 91 94 212 59 80 106 13 31 25
2023/2024530 32 20 36 6 28 202 112 7 6 36 6 39
2024/20251.199 56 239 164 10 15 47 25 110 111 68 145 209
2025/20262.945 218 126 331 392 240 155 475 195 327 230 184 72
2026/2027765 89 146 176 354 0 0 0 0 0 0 0 0
Totale 9.529